FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback